首页 › 基金 › BAKER BROS. ADVISORS LP › FTH

BAKER BROS. ADVISORS LP 对 FTH 的持仓历史

FAETH THERAPEUTICS INC

BAKER BROS. ADVISORS LP 在 Q2 2026 的 13F 申报中披露持有 FTH(FAETH THERAPEUTICS INC)1,286,411 股,市值约 US$32.2M,约占其申报组合的 0.17%,在其申报持仓中市值排名第 43 位。 BAKER BROS. ADVISORS LP 于 Q2 2026 首次申报该持仓。

最新持仓 (Q2 2026)1.29M 股
申报持仓市值$32.16M
组合权重0.17%
首次申报Q2 2026
最近变动新进
更新于2026-10-24

最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR

BAKER BROS. ADVISORS LP 对 FTH 的持仓演变

BAKER BROS. ADVISORS LP 于 Q2 2026 首次披露 FTH 持仓:1,286,411 股(约 US$32.2M)。

逐季持仓明细

季度股数金额变化
Q2 2026 1.29M $32.16M 新进

关于 FTH 与 13F 数据

FTH(FAETH THERAPEUTICS INC)的行业分类暂缺。我们追踪的基金中还有 46 只申报持有 FTH,申报仓位最大的包括:MONTANOVA CAPITAL, LLC (US$50.5M), Avoro Capital Advisors LLC (US$36.1M), Fairmount Funds Management LLC (US$18.1M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 FTH 的基金

查看 FTH 的全部基金持有人 →

常见问题

How long has BAKER BROS. ADVISORS LP held FTH?

BAKER BROS. ADVISORS LP has disclosed FTH holdings in 1 of the last 1 reported quarters, going back to Q2 2026.

What is BAKER BROS. ADVISORS LP's current position in FTH?

As of Q2 2026, BAKER BROS. ADVISORS LP holds 1.29M shares of FTH (FAETH THERAPEUTICS INC), valued at $32.16M, representing 0.17% of its reported portfolio and ranking #43.

Has BAKER BROS. ADVISORS LP been buying or selling FTH?

In the latest 13F filing (Q2 2026), BAKER BROS. ADVISORS LP newly opened its position in FTH.

Which other funds hold FTH?

Other major institutional holders of FTH include MONTANOVA CAPITAL, LLC, Avoro Capital Advisors LLC, Fairmount Funds Management LLC, among 46 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.